Please enable JS


Our development efforts are currently focused on advancing our pipeline by utilizing specific insights into early and advanced clinical development and regulatory pathways in China. We believe that successful drug development requires not only scientific and clinical rigor, but also a strategic focus and expertise on how to navigate the regulatory environment with patient benefit as the guiding principle.